Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma

British Journal of Clinical Pharmacology

Volumn 62, Issue 4, 2006, Pages 412-419

  Mortimer, Kevin J ^a,c   Harrison, Tim W ^a   Tang, Yufei ^b   Wu, Kai ^a   Lewis, Sarah ^a   Sahasranaman, Srikumar ^b   Hochhaus, Gunther ^b   Tattersfield, Anne E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF FLORIDA   (United States)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Airflow obstruction; Asthma; Inhaled corticosteroid; Pharmacology

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; MOMETASONE FUROATE;

ADULT; AGED; AIRWAY OBSTRUCTION; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SOLUBILITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LINEAR REGRESSION ANALYSIS; LONG TERM CARE; LUNG FUNCTION; MALE; PREDICTION; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-ASTHMATIC AGENTS; AREA UNDER CURVE; ASTHMA; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; VITAL CAPACITY;

EID: 33748748971     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02712.x     Document Type: Article

References (23)

1. Tattersfield AE, Harrison TW, Hubbard R, Mortimer K. Safety of inhaled corticosteroids. Proc Am Thorac Soc 2004; 1: 171-5.
2. Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 2004; 1: 356-63.
3. Brutsche MH, Brutsche IC, Munavvar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 2000; 356 (9229): 556-61.
4. Harrison TW, Tattersfield AE. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax 2003; 58: 258-60.
5. Harrison TW, Wisniewski A, Honour J, Tattersfield AE. Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax 2001; 56: 186-91.
6. Singh SD, Whale C, Houghton N, Daley-Yates P, Kirby SM, Woodcock AA. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease. Br J Clin Pharmacol 2003; 55: 375-81.
7. Weiner P, Berar-Yanay N, Davidovich A, Magadle R. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate. Chest 1999; 116: 931-4.
8. Quanjer PH. Standardised lung function testing. Bull Eur Physiopath Resp 1983; 19 (Suppl 5): 1-95.
9. Dimova H, Wang Y, Pommery S, Moellmann H, Hochhaus G. SPE/ RIA vs LC/MS for measurement of low levels of budesonide in plasma. Biomed Chromatogr 2003; 17: 14-20.
10. Krishnaswami S, Mollmann H, Derendorf H, Hochhaus G. A sensitive LC-MS/MS method for the quantification of fluticasone propionate in human plasma. J Pharmaceut Biomed Anal 2000; 22: 123-9.
11. Wang Y, Hochhaus G. Simultaneous quantification of beclomethasone dipropionate and its metabolite, beclomethasone 17-monopropionate in rat and human plasma and different rat tissues by liquid chromatography-positive electrospray ionization tandem mass spectrometry. Anal Technol Biomed Life Sci 2004; 805: 203-10.
12. Sahasranaman S, Tang Y, Biniasz D, Hochhaus G. A sensitive liquid chromatography-tandem mass spectrometry method for the quantification of mometasone furoate in human plasma. J Chromatogr 2005; 819: 175-9.
13. Nunn AJ, Gregg I. New regression equations for predicting peak expiratory flow in adults. BMJ 1989; 298: 1068-70.
14. Mollmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stockmann R, Barth J, Lawlor C, Mollmann AC, Derendorf H, Hochhaus G. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects. J Clin Pharmacol 2001; 41: 1329-38.
15. Thorsson L, Edsbacker S, Kallen A, Lofdahl CG. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br J Clin Pharmacol 2001; 52: 529-38.
16. Johnson M. Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids. J Allergy Clin Immunol 1996; 97: 169-76.
17. Thorsson L, Edsbacker S, Conradson TB. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler (P-MDI). Eur Respir J 1994; 7: 1839-44.
18. Daley-Yates PT, Price AC, Sisson JR, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001; 51: 400-9.
19. Ryrfeldt A, Andersson P, Edsbacker S, Tonnesson M, Davies D, Pauwels R. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Resp Dis 1982; 122 (Suppl.): 86-95.
20. Falcoz C, Oliver R, McDowall JE, Ventresca P, Bye A, Daley-Yates PT. Bioavailability of orally administered micronised fluticasone propionate. Clin Pharmacokinetics 2003; 39 (Suppl. 1): 9-15.
21. Agertoft L, Laulund LW, Harrison LI, Pedersen S. Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children. Pediatric Pulmonol 2003; 35: 192-9.
22. Harrison LI, Kurup S, Wagner C, Ekholm BP, Larson JS, Kaiser HB. Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma. Eur J Clin Pharmacol 2002; 58: 197-201.
23. Affrime MB, Cuss F, Padhi D, Wirth M, Pai S, Clement RP, Lim J, Kantesaria B, Alton K, Cayen MN. Bioavailability and metabolism of mometasone furoate following administration by metered-dose and dry-powder inhalers in healthy human volunteers. J Clin Pharmacol 2000; 40: 1227-36.